Study Reveals Only 1.1% of US Adults Tested for Lipoprotein(a) Despite Guideline Recommendations
By
Patrick Campbell
Summary
A Family Heart Database analysis presented at the 10th Annual Heart in Diabetes Meeting reveals that only 1.1% of US adults have undergone lipoprotein(a) testing, despite current dyslipidemia guidelines recommending measurement at least once during adulthood. A companion at-home screening program found elevated LDL-C and/or lipoprotein(a) levels in nearly two-thirds of results returned, highlighting a significant gap between guideline recommendations and real-world testing adoption.
Source
Key quotes
· 3 pulledA Family Heart Database analysis found lipoprotein(a) [Lp(a)] testing prevalence was just 1.1% among US adults
Current dyslipidemia guidelines recommend lipoprotein(a) measurement at least once during adulthood, yet adoption of universal testing has lagged
A companion at-home screening program identified elevated LDL-C and/or lipoprotein(a) levels in nearly two-thirds of results returned
You might also wanna read
Cardiovascular Disease Prevention Through Pharmaceutical LDL Reduction
The article argues that cardiovascular disease (CVD) is effectively a solved problem due to modern pharmaceutical interventions. It explains
totalhealthoptimization.com·5mo agoAmerica's Health Crisis and the New Dietary Guidelines: Restoring Real Food for National Health
The article discusses America's health crisis driven by highly processed foods, highlighting alarming statistics: 50% of Americans have pred
New Dietary Guidelines for Americans Emphasize Whole Foods to Address Health Crisis
The article discusses the new Dietary Guidelines for Americans, which emphasize whole, nutrient-dense, naturally occurring foods as the foun
Understanding and Preventing Heart Disease: A Comprehensive Guide
This comprehensive article by Jared Hecht addresses heart disease as the leading global cause of death, emphasizing that it's not just an is
Blood test added to screening guidelines for colorectal cancers
The Unintended Harms of Alzheimer's Biomarker Testing: Why Amyloid Isn't a Diagnosis
This article critically examines the growing trend of Alzheimer's Disease biomarker testing, arguing that testing for amyloid plaques does n
abpp.org·16d agoComments
Sign in to join the conversation.
No comments yet. Be the first.
